使:

Yong-Gang He1, Zheng Wang1, Jing Li1

  • 1Department of Hepatobiliary, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China.

概括

患者衍生器官 (PDO) 指导肝癌转化疗法的个性化药物选择. 这种方法使肝细胞癌患者在手术后能够实现病理完整的反应.